Genome‐wide methylomic analyses identify prognostic epigenetic signature in lower grade glioma.

MLA

Guo, Wenna, et al. “Genome‐wide Methylomic Analyses Identify Prognostic Epigenetic Signature in Lower Grade Glioma.” Journal of Cellular & Molecular Medicine, vol. 26, no. 2, Jan. 2022, pp. 449–61. EBSCOhost, https://doi.org/10.1111/jcmm.17101.

APA

Guo, W., Ma, S., Zhang, Y., Liu, H., Li, Y., Xu, J., Yang, B., & Guan, F. (2022). Genome‐wide methylomic analyses identify prognostic epigenetic signature in lower grade glioma. Journal of Cellular & Molecular Medicine, 26(2), 449–461. https://doi.org/10.1111/jcmm.17101

Chicago

Guo, Wenna, Shanshan Ma, Yanting Zhang, Hongtao Liu, Ya Li, Ji‐Tian Xu, Bo Yang, and Fangxia Guan. 2022. “Genome‐wide Methylomic Analyses Identify Prognostic Epigenetic Signature in Lower Grade Glioma.” Journal of Cellular & Molecular Medicine 26 (2): 449–61. doi:10.1111/jcmm.17101.